CRH binds to CRHR1 (CRH receptor 1) in the hypothalamus, which is responsible for depression-like behaviour; therefore, inhibiting CRHR1 activity may provide novel psychopharmacological therapeutics for depression [2]. The gene discussed is CRH; the disease is depressive symptom measurement.